David Vergote

725 total citations
19 papers, 609 citations indexed

About

David Vergote is a scholar working on Psychiatry and Mental health, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, David Vergote has authored 19 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 5 papers in Physiology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in David Vergote's work include Dementia and Cognitive Impairment Research (7 papers), Alzheimer's disease research and treatments (3 papers) and Neurobiology and Insect Physiology Research (3 papers). David Vergote is often cited by papers focused on Dementia and Cognitive Impairment Research (7 papers), Alzheimer's disease research and treatments (3 papers) and Neurobiology and Insect Physiology Research (3 papers). David Vergote collaborates with scholars based in Canada, France and United States. David Vergote's co-authors include David Westaway, Jack H. Jhamandas, Roger A. Dixon, Christopher Power, Sandra A. Wiebe, Michel Salzet, G. Peggy McFall, Valérie Chopin, Cécile Cren‐Olivé and Morley D. Hollenberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

David Vergote

19 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Vergote Canada	15	143	99	97	75	74	19	609
Šimons Svirskis Latvia	14	152 1.1×	61 0.6×	53 0.5×	40 0.5×	39 0.5×	56	536
Hengwen Yang China	16	331 2.3×	38 0.4×	73 0.8×	44 0.6×	214 2.9×	35	798
Nicolás Pineda-Trujillo Colombia	14	253 1.8×	92 0.9×	248 2.6×	18 0.2×	71 1.0×	42	1.2k
Mariusz Sacharczuk Poland	16	228 1.6×	50 0.5×	126 1.3×	75 1.0×	59 0.8×	89	799
A. E. G. Tannenberg Australia	17	365 2.6×	83 0.8×	176 1.8×	52 0.7×	49 0.7×	33	1.1k
Virginia Protto Italy	13	179 1.3×	23 0.2×	163 1.7×	31 0.4×	108 1.5×	18	680
Stefania Ciafrè Italy	18	391 2.7×	48 0.5×	83 0.9×	40 0.5×	74 1.0×	19	859
Stephen Hadley United States	12	298 2.1×	37 0.4×	82 0.8×	133 1.8×	58 0.8×	19	1.0k
Woan‐Ru Lin United Kingdom	8	234 1.6×	97 1.0×	404 4.2×	25 0.3×	87 1.2×	8	930
Yuzhen Liu China	15	265 1.9×	22 0.2×	110 1.1×	76 1.0×	42 0.6×	45	659

Countries citing papers authored by David Vergote

Since Specialization

Citations

This map shows the geographic impact of David Vergote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Vergote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Vergote more than expected).

Fields of papers citing papers by David Vergote

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Vergote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Vergote. The network helps show where David Vergote may publish in the future.

Co-authorship network of co-authors of David Vergote

This figure shows the co-authorship network connecting the top 25 collaborators of David Vergote. A scholar is included among the top collaborators of David Vergote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Vergote. David Vergote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

McFall, G. Peggy, et al.. (2022). Bridging Integrator 1 (BIN1, rs6733839) and Sex Are Moderators of Vascular Health Predictions of Memory Aging Trajectories. Journal of Alzheimer s Disease. 89(1). 265–281. 2 indexed citations

Chung, Jae Min, David Vergote, Ahmed F. Mohamed, et al.. (2018). Endosomal-Lysosomal Cholesterol Sequestration by U18666A Differentially Regulates Amyloid Precursor Protein (APP) Metabolism in Normal and APP-Overexpressing Cells. Molecular and Cellular Biology. 38(11). 11 indexed citations

Maulik, Mahua, et al.. (2017). The Effects of Extracellular Serum Concentration on APP Processing in Npc1-Deficient APP-Overexpressing N2a Cells. Molecular Neurobiology. 55(7). 5757–5766. 2 indexed citations

McFall, G. Peggy, Sandra A. Wiebe, David Vergote, Kaarin J. Anstey, & Roger A. Dixon. (2015). Alzheimer's genetic risk intensifies neurocognitive slowing associated with diabetes in nondemented older adults. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 1(4). 395–402. 20 indexed citations

DeCarlo, Correne A., Stuart MacDonald, David Vergote, et al.. (2015). Vascular Health and Genetic Risk Affect Mild Cognitive Impairment Status and 4-Year Stability: Evidence From the Victoria Longitudinal Study. The Journals of Gerontology Series B. 71(6). 1004–1014. 14 indexed citations

McFall, G. Peggy, Sandra A. Wiebe, David Vergote, et al.. (2014). ApoE and pulse pressure interactively influence level and change in the aging of episodic memory: Protective effects among ε2 carriers.. Neuropsychology. 29(3). 388–401. 27 indexed citations

Sapkota, Shraddha, David Vergote, David Westaway, Jack H. Jhamandas, & Roger A. Dixon. (2014). Synergistic associations of catechol-O-methyltransferase and brain-derived neurotrophic factor with executive function in aging are selective and modified by apolipoprotein E. Neurobiology of Aging. 36(1). 249–256. 23 indexed citations

McFall, G. Peggy, Sandra A. Wiebe, David Vergote, et al.. (2014). IDE (rs6583817) polymorphism and pulse pressure are independently and interactively associated with level and change in executive function in older adults.. Psychology and Aging. 29(2). 418–430. 27 indexed citations

Dixon, Roger A., Correne A. DeCarlo, Stuart MacDonald, et al.. (2014). APOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment. Frontiers in Aging Neuroscience. 6. 236–236. 35 indexed citations

10.

McFall, G. Peggy, Sandra A. Wiebe, David Vergote, et al.. (2013). IDE (rs6583817) polymorphism and type 2 diabetes differentially modify executive function in older adults. Neurobiology of Aging. 34(9). 2208–2216. 21 indexed citations

11.

Wang, Yanlin, et al.. (2012). Role of Cathepsin D in U18666A-induced Neuronal Cell Death. Journal of Biological Chemistry. 288(5). 3136–3152. 53 indexed citations

12.

Boidin‐Wichlacz, Céline, David Vergote, Christian Slomianny, et al.. (2011). Morphological and functional characterization of leech circulating blood cells: role in immunity and neural repair. Cellular and Molecular Life Sciences. 69(10). 1717–1731. 19 indexed citations

13.

Zhu, Yu, David Vergote, Carlos A. Pardo, et al.. (2009). CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy. The FASEB Journal. 23(9). 2928–2941. 38 indexed citations

14.

Tsutsui, Shigeki, David Vergote, Neda Shariat, et al.. (2007). Glucocorticoids regulate innate immunity in a model of multiple sclerosis: reciprocal interactions between the A1 adenosine receptor and β‐arrestin‐1 in monocytoid cells. The FASEB Journal. 22(3). 786–796. 40 indexed citations

15.

Vergote, David, Eduardo R. Macagno, Michel Salzet, & P. Sautière. (2006). Proteome modifications of the medicinal leech nervous system under bacterial challenge. PROTEOMICS. 6(17). 4817–4825. 8 indexed citations

16.

Vergote, David, Georgina S. Butler, Jennifer H. Cox, et al.. (2006). Proteolytic processing of SDF-1α reveals a change in receptor specificity mediating HIV-associated neurodegeneration. Proceedings of the National Academy of Sciences. 103(50). 19182–19187. 84 indexed citations

17.

Vergote, David, Anne Bouchut, P. Sautière, et al.. (2004). Characterisation of proteins differentially present in the plasma of Biomphalaria glabrata susceptible or resistant to Echinostoma caproni. International Journal for Parasitology. 35(2). 215–224. 61 indexed citations

18.

Vergote, David, P. Sautière, Franck Vandenbulcke, et al.. (2004). Up-regulation of Neurohemerythrin Expression in the Central Nervous System of the Medicinal Leech, Hirudo medicinalis, following Septic Injury. Journal of Biological Chemistry. 279(42). 43828–43837. 26 indexed citations

19.

Vergote, David, Cécile Cren‐Olivé, Valérie Chopin, et al.. (2002). (−)-Epigallocatechin (EGC) of Green Tea Induces Apoptosis of Human Breast Cancer Cells But Not of their Normal Counterparts. Breast Cancer Research and Treatment. 76(3). 195–201. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact